THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 116 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $52,496 | +9.4% | 6,083 | +31.2% | 0.00% | 0.0% |
| Q2 2023 | $47,993 | -4.6% | 4,637 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $50,311 | -0.5% | 4,637 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $50,543 | +7.5% | 4,637 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $47,000 | +11.9% | 4,637 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $42,000 | -4.5% | 4,637 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $44,000 | -13.7% | 4,637 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $51,000 | +82.1% | 4,637 | +22.2% | 0.00% | +100.0% |
| Q3 2021 | $28,000 | -49.1% | 3,794 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $55,000 | -28.6% | 3,794 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $77,000 | +1.3% | 3,794 | -11.4% | 0.00% | 0.0% |
| Q4 2020 | $76,000 | +20.6% | 4,282 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $63,000 | -30.0% | 4,282 | 0.0% | 0.00% | -25.0% |
| Q2 2020 | $90,000 | -2.2% | 4,282 | +7.8% | 0.00% | -20.0% |
| Q1 2020 | $92,000 | -3.2% | 3,972 | +8.3% | 0.01% | +25.0% |
| Q4 2019 | $95,000 | +33.8% | 3,666 | 0.0% | 0.00% | +33.3% |
| Q3 2019 | $71,000 | +18.3% | 3,666 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $60,000 | -27.7% | 3,666 | 0.0% | 0.00% | -25.0% |
| Q1 2019 | $83,000 | -11.7% | 3,666 | 0.0% | 0.00% | -20.0% |
| Q4 2018 | $94,000 | -21.7% | 3,666 | 0.0% | 0.01% | -16.7% |
| Q3 2018 | $120,000 | +44.6% | 3,666 | 0.0% | 0.01% | +50.0% |
| Q2 2018 | $83,000 | -6.7% | 3,666 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $89,000 | -40.7% | 3,666 | -5.1% | 0.00% | -42.9% |
| Q4 2017 | $150,000 | +20.0% | 3,865 | 0.0% | 0.01% | +16.7% |
| Q3 2017 | $125,000 | -18.3% | 3,865 | 0.0% | 0.01% | -14.3% |
| Q2 2017 | $153,000 | +15.0% | 3,865 | +6.3% | 0.01% | 0.0% |
| Q1 2017 | $133,000 | +1800.0% | 3,635 | +1494.3% | 0.01% | – |
| Q4 2016 | $7,000 | -12.5% | 228 | 0.0% | 0.00% | – |
| Q3 2016 | $8,000 | +60.0% | 228 | 0.0% | 0.00% | – |
| Q2 2016 | $5,000 | +25.0% | 228 | 0.0% | 0.00% | – |
| Q1 2016 | $4,000 | +33.3% | 228 | 0.0% | 0.00% | – |
| Q4 2015 | $3,000 | – | 228 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 7,012,226 | $60,515,510 | 8.59% |
| Irenic Capital Management LP | 2,760,948 | $23,826,981 | 6.76% |
| Newtyn Management, LLC | 1,841,560 | $15,892,663 | 3.92% |
| Weiss Asset Management LP | 7,457,060 | $64,354,428 | 3.81% |
| Park West Asset Management LLC | 1,983,251 | $17,115,456 | 1.57% |
| Baupost Group | 7,419,226 | $64,028 | 1.23% |
| Oasis Management Co Ltd. | 953,254 | $8,226,582 | 0.36% |
| Chescapmanager LLC | 287,333 | $2,479,684 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 325,985 | $2,813 | 0.24% |
| Virtus ETF Advisers LLC | 29,232 | $252,272 | 0.15% |